Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Caplin Point Labs Share Price
Caplin Point Laboratories Ltd.
₹2,067
Invest in CAPLIPOINT with up to 2.50x margin.
Trade with MTFCaplin Point Labs Performance
Price Movement
₹2033.40
₹2075.00
1 Year Performance
₹1500.30
₹2395.00
Markets Today
Historical Performance
Caplin Point Labs Fundamentals
Caplin Point Labs Financials
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 191.36 | 189.22 | 175.18 | 182.57 | 173.61 |
| Operating Expense | 107.77 | 97.50 | 99.33 | 95.96 | 98.57 |
| Operating Profit | 83.59 | 91.72 | 75.85 | 86.61 | 75.04 |
| Depreciation | 6.90 | 6.37 | 6.02 | 6.14 | 6.09 |
| Interest | 0.05 | 0.07 | 0.05 | 0.04 | 0.04 |
| Tax | 28.22 | 29.73 | 26.41 | 26.57 | 23.66 |
| Net Profit | 109.50 | 87.28 | 102.59 | 85.89 | 86.50 |
Caplin Point Labs Technicals
Caplin Point Laboratories Ltd. EMA & SMA
₹2067.00
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
Caplin Point Labs Support and Resistance
Resistance
Support
Technical Indicators
Caplin Point Labs Shareholding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 70.6 | 70.6 | 70.6 | 70.6 | 70.6 | 70.6 |
| FII | 4.9 | 5.7 | 6.2 | 6.5 | 6.6 | 6.2 |
| DII | 2.1 | 2 | 2.2 | 2.1 | 2 | 2.1 |
| Public | 22.5 | 21.7 | 21.1 | 20.8 | 20.8 | 21.1 |
Caplin Point Labs Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.01 L | 2.27 L | 44.57% |
| Week | 1.33 L | 6.76 L | 19.66% |
| 1 Month | 65.86 K | 2.28 L | 28.85% |
| 6 Month | 44.31 K | 1.05 L | 42.40% |
Caplin Point Labs SWOT Analysis
Benjamin Graham Value Screen
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Increasing Revenue every Quarter for the past 8 Quarters
Companies with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Increasing profits every quarter for the past 4 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
Stocks Outperforming their Industry Price Change in the Quarter
Caplin Point Labs Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 29 May, 2026 | 4 | INTERIM | 30 May, 2026 | Equity Share |
| 12 Sep, 2025 | 3 | FINAL | 12 Sep, 2025 | Equity Share |
| 30 May, 2025 | 3 | INTERIM | 30 May, 2025 | Equity Share |
| 23 Sep, 2024 | 2.5 | FINAL | Equity Share | |
| 31 May, 2024 | 2.5 | INTERIM | 31 May, 2024 | Equity Share |
| 14 Sep, 2023 | 2.5 | FINAL | Equity Share | |
| 09 Jun, 2023 | 2 | INTERIM | 09 Jun, 2023 | Equity Share |
| 21 Sep, 2022 | 2 | FINAL | Equity Share | |
| 23 May, 2022 | 2 | INTERIM | 24 May, 2022 | Equity Share |
| 20 Sep, 2021 | 1.5 | FINAL | Equity Share |
Caplin Point Labs Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,699.90 | ₹724.95 | ₹953.50 | ₹1,145.70 | ₹4,689.70 | ₹519.30 |
| % Change | 0.91% | 7.66% | 0.39% | 3.13% | -0.96% | -0.14% |
| Revenue TTM (₹ Cr) | ₹1,403.18 | - | ₹1,598.19 | ₹649.50 | ₹935 | ₹4,359.02 |
| Net Profit TTM (₹ Cr) | ₹185.12 | - | ₹206.20 | ₹115.38 | ₹257.90 | ₹255.19 |
| PE TTM | 57.20 | - | 78.90 | 43.30 | 43.40 | 31.80 |
| 1 Year Return | 63.07 | 9.63 | 103.31 | 111.14 | -2.21 | -6.77 |
| ROCE | 31.54 | 34.78 | 34.76 | 15.60 | - | 11.40 |
Similar Stocks
BLUEJET
Blue Jet Healthcare Ltd
₹ 445.35
+0.97%
CONCORDBIO
Concord Biotech Ltd.
₹ 1156.70
+0.29%
AARTIPHARM
Aarti Pharmalabs Ltd.
₹ 727.80
+2.06%
SUPRIYA
Supriya Lifescience Ltd.
₹ 783.45
+1.21%
ALIVUS
Alivus Life Sciences Ltd.
₹ 1041.50
+0.24%
COHANCE
Cohance Lifesciences Ltd.
₹ 428.75
+2.44%
ERIS
Eris Lifesciences Ltd.
₹ 1345.10
+0.10%
SYNGENE
Syngene International Ltd.
₹ 465.80
+0.86%
APLLTD
Alembic Pharmaceuticals Ltd.
₹ 757.50
+0.24%
SPARC
Sun Pharma Advanced Research Company Ltd.
₹ 226.41
+7.93%
STAR
Strides Pharma Science Ltd.
₹ 1176.60
+2.03%
GRANULES
Granules India Ltd.
₹ 760.30
+1.11%
FDC
FDC Ltd.
₹ 369.70
-0.95%
SHILPAMED
Shilpa Medicare Ltd.
₹ 510.85
+4.20%
JUBLPHARMA
Jubilant Pharmova Ltd.
₹ 970.00
-3.61%
MARKSANS
Marksans Pharma Ltd.
₹ 218.90
+3.32%
SANOFI
Sanofi India Ltd.
₹ 3159.40
-0.12%
PGHL
Procter & Gamble Health Ltd.
₹ 5601.00
+0.86%
JSLL
Jeena Sikho Lifecare Ltd.
₹ 628.00
-3.35%
FAQ's on CAPLIPOINT
What is the current share price of Caplin Point Laboratories Ltd.?
What is the Market Capitalization of Caplin Point Laboratories Ltd.?
What are the PE and PB ratios for Caplin Point Laboratories Ltd.?
What is the 52-Week High and Low for Caplin Point Laboratories Ltd.?
What is the current dividend yield for Caplin Point Laboratories Ltd.?
Who are the major shareholders of Caplin Point Laboratories Ltd.?
- Promoter
- Public
- FII
- Mutual Funds
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Caplin Point Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Caplin Point Laboratories Ltd.?
By signing up I certify terms, conditions & privacy policy